Results 161 to 170 of about 103,375 (340)

The Changing Transplant Landscape in the Era of Elexacaftor/Tezacaftor/Ivacaftor: A Word of Caution

Clinical Transplantation, Volume 39, Issue 10, October 2025.
ABSTRACT Background Elexacaftor/tezacaftor/ivacaftor (ETI) has dramatically changed the landscape of cystic fibrosis (CF) care, including in those who require lung transplantation. The objectives of the study were to describe the cohort demographics and outcomes of primary lung transplant recipients before and after the availability of ETI.
Julie Semenchuk, Eliza Tuff‐Gordon, Xiayi Ma, Jenna Sykes, Stephanie Y. Cheng, Meghan Aversa, Cecilia Chaparro, Elizabeth Tullis, Anne L. Stephenson   +8 more
wiley   +1 more source

Pulmonary aspergillosis associated with antineutrophil cytoplasmic antibody-positive vasculitis involving skin and peripheral nerves

Journal of the Indian Academy of Geriatrics
Invasive pulmonary aspergillosis is the most common cause of invasive fungal infection. Vasculitis secondary to bacterial, fungal, viral, and parasitic infections is documented in the literature.
Abhijith Rajaram Rao, Mohamed Rishan, Prakruthi Jaladhar, Prabha Adhikari   +3 more
doaj   +1 more source

Significance and interpretation of laboratory tests in pulmonary aspergillosis [PDF]

, 1967
M. P. English, A. H. Henderson
openalex   +1 more source

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.

Clinical Infectious Diseases, 2016
T. Patterson, G. Thompson, D. Denning, J. Fishman, S. Hadley, R. Herbrecht, D. Kontoyiannis, K. Marr, V. Morrison, M. Nguyen, B. Segal, W. Steinbach, D. Stevens, T. Walsh, J. Wingard, Jo-Anne H. Young, J. Bennett   +16 more
semanticscholar   +1 more source

Treatment outcomes in sinonasal aspergillosis in dogs in the United Kingdom: 436 cases (2011‐2021)

Journal of Small Animal Practice, Volume 66, Issue 10, Page 683-692, October 2025.
Objectives A variety of treatment options for sinonasal aspergillosis have been described, encompassing non‐invasive and invasive approaches. To describe the clinical outcomes in dogs treated for sinonasal aspergillosis in the United Kingdom. Materials and Methods A multi‐centre retrospective survey was performed involving 23 referral centres in the ...
C. D. Prior, H. Swales, A. Kortum, N. Reed, M. Sharman, D. Kelly, A. Kent, B. Glanemann, K. Clarke, C. Lea, E. Roberts, N. Bommer, L. Rutherford, A. Tamborini, K. Murphy, D. J. Batchelor, S. Calleja, R. Burrow, P. M. Jamieson, C. Piazza, M. Best, I. Calvo Saiz, I. Elgueta, S. J. Fowlie, C. Shales, C. Gil Morales, E. Lopez, S. Borgonovi, M. Keane, J. Kennils, E. Izaguirre, M. Hernandez‐Perello, N. Lau, A. Paul, A. Ridyard, E. Shelton, A. Farges, G. Specchia, L. Espada, S. Spence, A. Hrovat, N. Van den Steen, S. Tappin, T. H. Sparks, F. Allerton   +44 more
wiley   +1 more source

Pulmonary Aspergillosis: A Review and a Description of Three New Cases [PDF]

, 1964
J Macartney
openalex   +1 more source

Breakthrough Invasive Mould Infections Under Posaconazole Prophylaxis in Patients With Haematologic Malignancies: A Case–Control Study

Mycoses, Volume 68, Issue 10, October 2025.
ABSTRACT Background Posaconazole (POS) prophylaxis is recommended for the prevention of invasive mould infections among patients with haematologic cancer and prolonged neutropenia or following allogeneic haematopoietic cell transplantation. Albeit rare, breakthrough invasive mould infections (bIMI) are associated with high mortality rates.
Camille Marchetti, Emmanouil Glampedakis, Jannik Stemler, Luise Hänsel, Sabine Kuster, Ilona Kronig, Katia Boggian, Nina Khanna, Dionysios Neofytos, Oliver A. Cornely, Frederic Lamoth, for the Fungal Infection Network of Switzerland (FUNGINOS), Werner Albrich, Christoph Berger, Anne Bergeron, Sabina Berezowska, Pierre‐Yves Bochud, Katia Boggian, Anna Conen, Stéphane Emonet, Véronique Erard, Christian Garzoni, Daniel Goldenberger, Vladimira Hinic, Cedric Hirzel, Nina Khanna, Malte Kohns, Andreas Kronenberg, Frederic Lamoth, Basile Landis, Oscar Marchetti, Konrad Mühlethaler, Linda Müller, Dionysios Neofytos, Michael Osthoff, Jean‐Luc Pagani, Chantal Quiblier, Ilana Reinhold, Arnaud Riat, Niels Rupp, Dominique Sanglard, Peter Werner Schreiber, Martin Siegemund, Laura Walti   +43 more
wiley   +1 more source

Severe pulmonary aspergillosis post viral illness in immunocompetent patients: A case series

Respiratory Medicine Case Reports
Invasive pulmonary aspergillosis (IPA) is a life-threatening disease commonly affecting the lungs of immunosuppressed patients. Recently, Aspergillosis was diagnosed in immunocompetent patients with viral pneumonia due to influenza virus and coronavirus ...
Moujaes Ghassan, Sleiman Wissam
doaj   +1 more source

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

New England Journal of Medicine, 2002
R. Herbrecht, D. Denning, T. Patterson, J. Bennett, R. Greene, J. Oestmann, W. Kern, K. Marr, P. Ribaud, O. Lortholary, R. Sylvester, R. Rubin, J. Wingard, P. Stark, C. Durand, D. Caillot, E. Thiel, P. Chandrasekar, M. Hodges, H. Schlamm, P. Troke, B. D. de Pauw   +21 more
semanticscholar   +1 more source

Is galactomannan a useful tool for triage and diagnosis of oral invasive aspergillosis?

Hematology, Transfusion and Cell Therapy
Objective: To evaluate the accuracy of the galactomannan serum test in diagnosing oral invasive aspergillosis. Methods: This prospective observational study included oncohematological neutropenic patients with suspected invasive aspergillosis, but ...
Maria Júlia Pagliarone, Lara Maria Alencar Ramos Innocentini, Fernanda Bortolotto, Vanessa Tonetto Marques Galves, Hilton Marcos Alves Ricz, Tatiane Cristina Ferrari, Renato Luiz Guerino Cunha, Belinda Pinto Simões, Leandro Dorigan de Macedo   +8 more
doaj   +1 more source